+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis



Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis



Journal of Gastroenterology and Hepatology 21(2): 413-419



To compare the efficacy and safety of endoscopic variceal ligation (EVL) with propranolol in prophylaxis on the rate of first esophageal variceal bleeding in patients with cirrhosis. A prospective, randomized trial was conducted in 100 cirrhotic patients with no history of previous upper gastrointestinal bleeding and with esophageal varices endoscopically judged to be at high risk of hemorrhage. The end-points of the study were bleeding and death. Life-table curves showed that prophylactic EVL and propranolol were similarly effective for primary prophylaxis of variceal bleeding (11/50 [22%]vs 12/50 [24%]; P = 0.68) and overall mortality (14/50 [28%]vs 12/50 [24%]; P = 0.49). The 2-year cumulative bleeding rate was 18% (9/50) in the EVL group and 16% (8/50) in the propranolol group. The 2-year cumulative mortality rate was 28% (14/50) in the EVL group and 24% (12/50) in the propranolol group. Comparison of Kaplan-Meier estimates of the time to death of both groups showed no significant difference in mortality in both groups (P = 0.86). Patients undergoing EVL had few treatment failures and died mainly of hepatic failure. In the propranolol group, the mean daily dosage of the drug was 68.2 +/- 32.8 mg, which was sufficient to reduce the pulse rate by 25%. 20% of patients withdrew from propranolol treatment due to adverse events. Prophylaxis EVL is as effective and as safe as treatment with propranolol in decreasing the incidence of first variceal bleeding and death in cirrhotic patients with high-risk esophageal varices.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012037039

Download citation: RISBibTeXText

PMID: 16509867

DOI: 10.1111/j.1440-1746.2005.04071.x


Related references

Combination of endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in the primary prophylaxis of oesophageal variceal bleeding An interim analysis. Hepatology 34(4 Pt 2): 534A, 2001

Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. American Journal of Gastroenterology 100(4): 797-804, 2005

Variceal band ligation versus propranolol for primary prophylaxis of variceal bleeding in cirrhosis. Current Gastroenterology Reports 7(3): 175-176, 2005

Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus EVL alone in secondary prophylaxis of variceal bleeding: A prospective RCT. 2007

Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding. Annals of Hepatology 10(2): 142-149, 2011

Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study. Journal of Hepatology 26(5): 1034-1041, 1997

Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 40(1): 65-72, 2004

Comparison of endoscopic band ligation and propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 37(5): 513-516, 2012

Endoscopic variceal ligation combined with argon plasma coagulation versus ligation alone for the secondary prophylaxis of variceal bleeding: a systematic review and meta-analysis. European Journal of Gastroenterology and Hepatology 29(6): 621-628, 2017

Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices. Annals of Hepatology 9(1): 15-22, 2010

The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective β-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis. European Journal of Gastroenterology and Hepatology 31(12): 1518-1526, 2019

Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology 139(4): 1238-1245, 2010

The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding. Clinical and Molecular Hepatology 20(3): 283-290, 2014

Embolization combined with endoscopic variceal ligation for the treatment of esophagogastric variceal bleeding in patients with cirrhosis. Chinese Medical Journal 120(1): 36-40, 2007

Randomized trial of propranolol vs endoscopic variceal ligation in the primary prophylaxis of bleeding from high risk varices in cirrhosis An interim analysis. Hepatology 26(4 Part 2): 360A, 1997